Proteomics
Technologies are available for identifying and characterizing the protein signatures of human cancer cells and tissues and for applying proteomics technologies directly to patient diagnosis, toxicity monitoring, and therapeutic intervention.
Proteomics
Technologies are available for identifying and characterizing the protein signatures of human cancer cells and tissues and for applying proteomics technologies directly to patient diagnosis, toxicity monitoring, and therapeutic intervention. Expertise also exists for:
- Designing protein expression and purification schemes
- Identifying protein interactions
- Identifying sites of phosphorylation
- Validating protein interactions
- Bioinformatically analyzing proteomic results
Contact Us
For access to these and other technologies, please see the Advanced Technology Program page on the NCI−Frederick web site or contact:
Robert Fisher, Ph.D.
(301) 846-5154
(301) 846-7392 Fax
fisher@ncifcrf.gov